Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Tax Provisions (2016 - 2025)

Iradimed (IRMD) has disclosed Tax Provisions for 13 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Tax Provisions rose 25.73% to $1.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.4 million, a 28.92% increase, with the full-year FY2024 number at $5.7 million, up 26.26% from a year prior.
  • Tax Provisions was $1.7 million for Q3 2025 at Iradimed, up from $1.6 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.9 million in Q4 2024 to a low of -$779172.0 in Q4 2021.
  • A 5-year average of $979767.9 and a median of $1.1 million in 2024 define the central range for Tax Provisions.
  • Biggest YoY gain for Tax Provisions was 284.56% in 2021; the steepest drop was 115.23% in 2021.
  • Iradimed's Tax Provisions stood at -$779172.0 in 2021, then surged by 223.92% to $965551.0 in 2022, then increased by 18.27% to $1.1 million in 2023, then skyrocketed by 65.97% to $1.9 million in 2024, then dropped by 9.19% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Tax Provisions are $1.7 million (Q3 2025), $1.6 million (Q2 2025), and $1.3 million (Q1 2025).